“The issue that arises in this case is of considerable importance. It relates to the patentability of genes, or gene sequences, and the practice of gene patenting”. So began the reasons for judgement of…
Academic rigor, journalistic flair
Articles on BRCA1
Displaying 21 - 23 of 23 articles
Private firms are allowed to hold a patent over cancer-causing gene mutations, according to an historic ruling in the Federal…
Mothers, sisters and daughters from breast cancer families with known genetic mutations do not all share the same high risk…
Top contributors
-
Adjunct Professor, Murdoch University
-
Professor of Law, University of Tasmania
-
Professorial Research Fellow. School of Psychology, Faculty of Health and Medical Sciences, University of Adelaide
-
Professor of Oncology, Head of the RMH Familial Cancer Centre and Joint Head, Breast Cancer Laboratory, Walter and Eliza Hall Institute
-
Executive Director, Melbourne Genomics Health Alliance, Walter and Eliza Hall Institute
-
Adjunct Fellow, School of Law & School of Medicine, Western Sydney University
-
PhD Candidate & Research Fellow, University of Tasmania
-
Professor of Women's Health Psychology, Translational Health Research Institute (THRI), Western Sydney University
-
Medical Oncologist and Laboratory Head, Walter and Eliza Hall Institute
-
Consultant Senior Lecturer in Clinical Genetics, UCL
-
Professor of Genetics, University of Newcastle
-
Professor, University of Melbourne
-
Research Fellow in Cancer Biology, Queen's University Belfast
-
Lab Head, Gynaecological Cancer Research Group, Lowy Cancer Rearch Centre, UNSW
-
Associate Professor and Program Authority, UNSW
